Lessons from postgenome-wide association studies: Functional analysis of cancer predisposition loci

Journal of Internal Medicine

Volumn 274, Issue 5, 2013, Pages 414-424

  Monteiro, A N A ^a   Freedman, M L ^b,c  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Cancer predisposition; eQTL; GWAS; SNPs; Transcription

Indexed keywords

TRANSCRIPTION FACTOR;

BACTERIAL ARTIFICIAL CHROMOSOME; BINDING SITE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL CANCER; DNA SEQUENCE; FUNCTIONAL GENOMICS; GENE CONTROL; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HISTONE ACETYLATION; HUMAN; HUMAN GENOME; LUNG CANCER; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; QUANTITATIVE TRAIT LOCUS; REVIEW; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; SOMATIC MUTATION;

CANCER PREDISPOSITION; EQTL; GWAS; SNPS; TRANSCRIPTION;

GENES; GENETIC LINKAGE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84885716197     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12085     Document Type: Review

References (57)

1. Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science 2001; 291: 1304-51.
2. Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
3. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P. A haplotype map of the human genome. Nature 2005; 437: 1299-320.
4. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010; 363: 166-76.
5. Maurano MT, Humbert R, Rynes E et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012; 337: 1190-5.
6. Sunyaev S, Ramensky V, Koch I, Lathe W III, Kondrashov AS, Bork P. Prediction of deleterious human alleles. Hum Mol Genet 2001; 10: 591-7.
7. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res 2001; 11: 863-74.
8. Karchin R, Diekhans M, Kelly L et al. LS-SNP: large-scale annotation of coding non-synonymous SNPs based on multiple information sources. Bioinformatics 2005; 21: 2814-20.
9. Reese MG, Eeckman FH, Kulp D, Haussler D. Improved splice site detection in Genie. J Comput Biol 1997; 4: 311-23.
10. Yeo G, Burge CB. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 2004; 11: 377-94.
11. Freedman ML, Monteiro AN, Gayther SA et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet 2011; 43: 513-8.
12. Bojesen SE, Pooley KA, Johnatty SE et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013; 45: 371-84.
13. Eeles RA, Olama AA, Benlloch S et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 2013; 45: 385-91, 391e381-82.
14. Pharoah P, Tsai YY, Ramus SJ et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 2013; 45: 362-70.
15. Michailidou K, Hall P, Gonzalez-Neira A et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013; 45: 353-61, 361e351-52.
16. Garcia-Closas M, Couch FJ, Lindstrom S et al. Genome-wide association studies identify four ER-negative specific breast cancer risk loci. Nat Genet 2013; 45: 392-98, 398e391-92.
17. French JD, Ghoussaini M, Edwards SL et al. Functional Variants at the 11q13 Breast Cancer Risk Loci Regulate Cyclin D1 Expression through Long-Range Enhancers. Am J Hum Genet 2013; 92: 489-503.
18. Gaudet MM, Kuchenbaecker KB, Vijai J et al. Identification of a BRCA2-specific Modifier Locus at 6p24 Related to Breast Cancer Risk. PLoS Genet 2013; 9: e1003173.
19. Couch FJ, Wang X, McGuffog L et al. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk. PLoS Genet 2013; 9: e1003212.
20. Varghese JS, Easton DF. Genome-wide association studies in common cancers-what have we learnt? Curr Opin Genet Dev 2010; 20: 201-9.
21. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001; 17: 502-10.
22. Berns EM, Bowtell DD. The changing view of high-grade serous ovarian cancer. Cancer Res 2012; 72: 2701-4.
23. 1000 Genomes Project Consortium, Abecasis GR, Altshuler D et al. A map of human genome variation from population-scale sequencing. Nature 2010;467:1061-73.
24. Cancer Genome Atlas Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011;474:609-15.
25. Hammerman PS, Hayes DN, Wilkerson MD et al. Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012; 489: 519-25.
26. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490: 61-70.
27. Neph S, Vierstra J, Stergachis AB et al. An expansive human regulatory lexicon encoded in transcription factor footprints. Nature 2012; 489: 83-90.
28. Thurman RE, Rynes E, Humbert R et al. The accessible chromatin landscape of the human genome. Nature 2012; 489: 75-82.
29. Dunham I, Kundaje A, Aldred SF et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489: 57-74.
30. Sanyal A, Lajoie BR, Jain G, Dekker J. The long-range interaction landscape of gene promoters. Nature 2012; 489: 109-13.
31. Djebali S, Davis CA, Merkel A et al. Landscape of transcription in human cells. Nature 2012; 489: 101-8.
32. Forbes SA, Bindal N, Bamford S et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011; 39: D945-50.
33. Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-9.
34. Shipley B. Cause and Correlation in Biology: A User's Guide to Path Analysis, Structural Equations, and Causal Inference. Cambridge, UK; New York, NY. USA: Cambridge University Press. 2000.
35. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009; 4: 1073-81.
36. Karchin R. Next generation tools for the annotation of human SNPs. Brief Bioinform 2009; 10: 35-52.
37. Thusberg J, Olatubosun A, Vihinen M. Performance of mutation pathogenicity prediction methods on missense variants. Hum Mutat 2011; 32: 358-68.
38. Hicks S, Wheeler DA, Plon SE, Kimmel M. Prediction of missense mutation functionality depends on both the algorithm and sequence alignment employed. Hum Mutat 2011; 32: 661-8.
39. Adzhubei IA, Schmidt S, Peshkin L et al. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248-9.
40. Karchin R, Monteiro AN, Tavtigian SV, Carvalho MA, Sali A. Functional impact of missense variants in BRCA1 predicted by supervised learning. PLoS ComputBiol 2007; 3: e26.
41. Abecasis GR, Auton A, Brooks LD et al. An integrated map of genetic variation from 1, 092 human genomes. Nature 2012; 491: 56-65.
42. Coetzee SG, Rhie SK, Berman BP, Coetzee GA, Noushmehr H. FunciSNP: an R/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs. Nucleic Acids Res 2012; 40: e139.
43. Boyle AP, Hong EL, Hariharan M et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012; 22: 1790-7.
44. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 2012; 40: D930-4.
45. Stranger BE, Forrest MS, Clark AG et al. Genome-wide associations of gene expression variation in humans. PLoSGenet 2005; 1: e78.
46. Cheung VG, Spielman RS. The genetics of variation in gene expression. Nat Genet 2002; 32(Suppl): 522-5.
47. Cheung VG, Conlin LK, Weber TM et al. Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet 2003; 33: 422-5.
48. Schadt EE, Monks SA, Drake TA et al. Genetics of gene expression surveyed in maize, mouse and man. Nature 2003; 422: 297-302.
49. Grisanzio C, Werner L, Takeda D et al. Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proc Natl Acad Sci U S A 2012; 109: 11252-7.
50. Li Q, Seo JH, Stranger B, et al. Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell 2013; 152: 633-41.
51. Barrett T, Wilhite SE, Ledoux P et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res 2012; 41: D991-5.
52. Giresi PG, Kim J, McDaniell RM, Iyer VR, Lieb JD. FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Res 2007; 17: 877-85.
53. Crawford GE, Holt IE, Whittle J et al. Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome Res 2006; 16: 123-31.
54. Dekker J, Rippe K, Dekker M, Kleckner N. Capturing chromosome conformation. Science 2002; 295: 1306-11.
55. Dekker J. The three 'C' s of chromosome conformation capture: controls, controls, controls. Nat Methods 2006; 3: 17-21.
56. Lawrenson K, Benjamin E, Turmaine M, Jacobs I, Gayther S, Dafou D. In vitro three-dimensional modelling of human ovarian surface epithelial cells. Cell Prolif 2009; 42: 385-93.
57. Gerstein MB, Kundaje A, Hariharan M et al. Architecture of the human regulatory network derived from ENCODE data. Nature 2012; 489: 91-100.